Novel Viral Vectors for Gene Therapy
Synthetic Viral Vectors Show Promise for Mitigating Immune Response to Gene Therapy
Virus Supply Vexes Gene Therapy Developers, CMOs
Some Contract Manufacturing Organizations Are Ramping Up Capacity in Preparation for a Boom in Viral Vector Demand
Ovarian Cancer Stem Cells: Unraveling a Germline Connection
Stem Cells, the Holy Grail for Tissue Regeneration and Repair, Remain an Elusive Phenomenon in Ovarian Biology
To Gild the Microbe Is Anything but Wasteful
Synthetic Biology Is Enabling Optimization that Is Iterative—and Remunerative
For full access to this article login to GEN Select now.
GEN Roundup: The Long and Short of NGS Sample Preparation
<i>GEN</I>’s expert panel explains the challenges that encompass Next-Generation Sequencing
- Ever since next-generation sequencing (NGS) was introduced, its main advantage has been its ability to outpace Sanger sequencing. NGS, unlike Sanger sequencing, is an array-based technique. It can process millions of reactions in parallel, dramatically increasing sequencing throughput. To gain this advantage in throughput, however, NGS had to ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.